|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.325 CAD | -2.99% |
|
-4.41% | -16.67% |
| Apr. 25 | Microbix to Present New Lab Accreditation Program at European Congress on Clinical Microbiology | MT |
| Mar. 27 | Transcript : Microbix Biosystems Inc. - Shareholder/Analyst Call |
Microbix Biosystems Inc. provided earnings guidance for the full-year fiscal 2024. The company expects to generate meaningful sales and net earnings growth across full-year fiscal 2024.
| 1st Jan change | Capi. | |
|---|---|---|
| -16.67% | 32.62M | |
| +1.51% | 42.75B | |
| +8.57% | 41.34B | |
| +49.22% | 41.61B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
MICROBIX BIOSYSTEMS INC. 
